Economic Evaluation of Anti-Vascular Endothelial Growth Factor Therapy for Wet Age-Related Macular Degeneration
- PMID: 31725831
- DOI: 10.1001/jamaophthalmol.2019.4582
Economic Evaluation of Anti-Vascular Endothelial Growth Factor Therapy for Wet Age-Related Macular Degeneration
Comment on
-
Economic Value of Anti-Vascular Endothelial Growth Factor Treatment for Patients With Wet Age-Related Macular Degeneration in the United States.JAMA Ophthalmol. 2020 Jan 1;138(1):40-47. doi: 10.1001/jamaophthalmol.2019.4557. JAMA Ophthalmol. 2020. PMID: 31725830 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
